Print This Page Email This Page Share on LinkedIn Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Pharmaceuticals & Fine Chemicals Clariant Will Not be Broken UpISP Among First to Obtain Pharmacopeia SealEFCG Welcomes Action on APIsCPhI: Dow Brings Synthetic Glycerine Business Back Under its DomainLonza Offers Cell Culture Medium Related Stories Fresenius Kabi Buys Indian Generics and API FirmGlenmark Buys Czech Pharma FirmIndian Firm is First to Join USP Verification ProgramIPS Opens Two Service Offices in IndiaAlembic Completes Acquisition of Dabur Pharma

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

November 21, 2007

Indian Pharma Firm to Spin off Generics and Ingredients

Deepti Ramesh

Glenmark Pharmaceuticals (Mumbai) says it plans to hive off its generic drugs and active pharmaceutical ingredient (API) businesses to create a new, wholly owned subsidiary, Glenmark Generics Ltd. (GGL). Glenmark expects to list the new company on the Indian...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers